When does Fresenius report earnings and how could it affect FRE.DE stock?

Fresenius reports Q4 on 25 Feb 2026 at 16:30 UTC. Results on margins, dialysis volumes, and guidance can move FRE.DE stock intraday, with upside if Medical Care margins exceed expectations and downside if guidance weakens.

What are the key valuation metrics to watch for Fresenius?

Watch **PE 25.23**, free cash flow yield **4.15%**, debt/equity **0.73**, and price-to-sales **1.30**. These show fair valuation but elevated leverage versus cash flow.

What price targets does Meyka AI give for FRE.DE stock?

Meyka AI's forecast model projects **EUR 55.47** monthly and **EUR 61.31** yearly. These imply roughly **6.51%** and **17.74%** upside respectively versus the current **EUR 52.08**.

What are the main risks investors should consider?

Main risks include dialysis pricing pressure, weaker hospital admissions, and the company's net debt to EBITDA of **3.34**. Any negative surprise on margins or cash flow could pressure FRE.DE stock.

DE Stocks

Earnings 25 Feb 2026: Fresenius SE (FRE.DE XETRA) impact on EUR 52.08 stock

ByDanny Kontos February 24, 2026February 24, 2026

FRE.DE stock trades at EUR 52.08 ahead of Fresenius SE & Co. KGaA’s earnings due 25 Feb 2026. The company reports after the close and the market is watching Fresenius Medical Care margins and Helios hospital volumes. Intraday volume sits at 591,547 versus an average of 671,873, keeping price action tight between a day low of EUR 51.72 and a day high of EUR 52.96. Investors should weigh segment profit momentum, valuation at PE 25.23, and cash flow metrics before the Q4 print.